
Strong issuance outlook and historic fundraising rebound position Hong Kong as a global IPO powerhouse into 2026
Hong Kong’s initial public offering market is charting an exceptional trajectory, underpinned by a deep pipeline of prospective listings and strong fundraising momentum that appear set to sustain a record year of activity.
The city reclaimed its position at the forefront of global IPO markets in 2025, buoyed by a surge in “A+H” listings — companies that list shares both on mainland China exchanges and in Hong Kong — and capital raising that vastly exceeded prior years’ totals.
Active IPO applications climbed to more than three hundred by late 2025, marking a substantial increase over earlier years and reflecting broad investor confidence in the market’s depth and appeal.
PwC Hong Kong forecasts that the overall trend of robust capital market activity will continue through 2026, with over a hundred companies expected to complete listings and funds raised potentially reaching new highs as diverse sectors — from technology and healthcare to traditional industries — pursue access to international capital.
Market conditions have strengthened as interest rates ease and regulatory reforms streamline the listing process, with tailored support channels for specialist technology and biotech firms further expanding the market’s breadth.
These developments affirm Hong Kong’s role as a vital fundraising hub for Asia-Pacific and highlight strong cross-border investor interest in equity capital markets across the region.
The city reclaimed its position at the forefront of global IPO markets in 2025, buoyed by a surge in “A+H” listings — companies that list shares both on mainland China exchanges and in Hong Kong — and capital raising that vastly exceeded prior years’ totals.
Active IPO applications climbed to more than three hundred by late 2025, marking a substantial increase over earlier years and reflecting broad investor confidence in the market’s depth and appeal.
PwC Hong Kong forecasts that the overall trend of robust capital market activity will continue through 2026, with over a hundred companies expected to complete listings and funds raised potentially reaching new highs as diverse sectors — from technology and healthcare to traditional industries — pursue access to international capital.
Market conditions have strengthened as interest rates ease and regulatory reforms streamline the listing process, with tailored support channels for specialist technology and biotech firms further expanding the market’s breadth.
These developments affirm Hong Kong’s role as a vital fundraising hub for Asia-Pacific and highlight strong cross-border investor interest in equity capital markets across the region.















































